​

Harrow Health (HROW) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HROW Stock Forecast

Harrow Health (HROW) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $73.00, with a high of $73.00 and a low of $73.00. This represents a 212.63% increase from the last price of $23.35.

$10 $23 $36 $49 $62 $75 High: $73 Avg: $73 Low: $73 Last Closed Price: $23.35

HROW Stock Rating

Harrow Health stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 8 Strong Sell Sell Hold Buy Strong Buy

HROW Price Target Upside V Benchmarks

TypeNameUpside
StockHarrow Health212.63%
SectorHealthcare Stocks 35.25%
IndustrySpecialty & Generic Drug Manufacturers Stocks47.55%

Price Target Trends

1M3M12M
# Anlaysts--6
Avg Price Target--$42.17
Last Closing Price$23.35$23.35$23.35
Upside/Downside--80.60%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2514---5
Mar, 2514---5
Feb, 25-4---4
Jan, 25-4---4
Dec, 24-4---4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 18, 2024Sahil KazmiB.Riley Financial$73.00$56.4129.41%212.63%
Oct 04, 2024Brooks O'NeilLake Street$55.00$49.7510.55%135.55%
Aug 09, 2024Chase KnickerbockerCraig-Hallum$45.00$35.2527.66%92.72%
Jun 21, 2024Chase KnickerbockerCraig-Hallum$30.00$19.9350.53%28.48%
Jun 03, 2024Brooks O'NeilLoop Capital Markets$25.00$17.6841.40%7.07%
Jun 03, 2024Brooks O'NeilLake Street$25.00$18.1337.89%7.07%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 01, 2025B. RileyBuyBuyhold
Oct 04, 2024J.P. MorganBuyBuyhold
Oct 04, 2024Craig-HallumBuyBuyhold
Oct 04, 2024Lake StreetBuyBuyhold
Aug 29, 2024Lake StreetBuyBuyhold
Aug 09, 2024Craig-HallumBuyBuyhold
Aug 09, 2024B. RileyBuyBuyhold
Jun 21, 2024Craig-HallumBuyBuyhold
Jun 03, 2024Lake StreetBuyBuyhold
May 15, 2024Craig-HallumBuyBuyhold

Financial Forecast

EPS Forecast

$-1 $0 $1 $2 $3 $4 $5 $6 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-0.13$-0.67$-0.51$-0.75$-0.49---
Avg Forecast$-0.09$-0.48$-0.67$-0.52$-0.64$0.57$2.29$5.28
High Forecast$-0.09$-0.47$-0.66$-0.50$-0.62$0.79$3.07$5.58
Low Forecast$-0.09$-0.50$-0.70$-0.55$-0.67$0.33$1.51$5.15
Surprise %44.44%39.58%-23.88%44.23%-23.44%---

Revenue Forecast

$0 $40T $80T $120T $160T $200T Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$48.87M$72.48M$88.59M$130.19M$199.61T---
Avg Forecast$48.73M$71.64M$89.54M$131.69M$191.85M$283.47M$427.48M$704.66M
High Forecast$49.85M$73.28M$92.57M$137.39M$200.16M$295.75M$446.00M$735.18M
Low Forecast$47.61M$70.00M$88.14M$129.12M$188.11M$277.94M$419.13M$690.90M
Surprise %0.28%1.16%-1.06%-1.13%104045455.83%---

Net Income Forecast

$-50M $0 $50M $100M $150M $200M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-3.42M$-18.01M$-14.09M$-24.41M$-17.48M---
Avg Forecast$-2.94M$-15.76M$-21.85M$-17.11M$-21.03M$21.49M$91.07M$174.88M
High Forecast$-2.85M$-15.29M$-21.41M$-16.42M$-20.19M$25.70M$100.13M$181.91M
Low Forecast$-3.02M$-16.23M$-22.82M$-17.80M$-21.88M$10.90M$49.25M$167.84M
Surprise %16.47%14.22%-35.54%42.65%-16.88%---

HROW Forecast FAQ

Is Harrow Health stock a buy?

Harrow Health stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Harrow Health is a favorable investment for most analysts.

What is Harrow Health's price target?

Harrow Health's price target, set by 8 Wall Street analysts, averages $73 over the next 12 months. The price target range spans from $73 at the low end to $73 at the high end, suggesting a potential 212.63% change from the previous closing price of $23.35.

How does Harrow Health stock forecast compare to its benchmarks?

Harrow Health's stock forecast shows a 212.63% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the specialty & generic drug manufacturers stocks industry (47.55%).

What is the breakdown of analyst ratings for Harrow Health over the past three months?

  • April 2025: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Harrow Health’s EPS forecast?

Harrow Health's average annual EPS forecast for its fiscal year ending in December 2025 is $0.57, marking a -216.33% decrease from the reported $-0.49 in 2024. Estimates for the following years are $2.29 in 2026, and $5.28 in 2027.

What is Harrow Health’s revenue forecast?

Harrow Health's average annual revenue forecast for its fiscal year ending in December 2025 is $283.47M, reflecting a -100.00% decrease from the reported $199.61T in 2024. The forecast for 2026 is $427.48M, and $704.66M for 2027.

What is Harrow Health’s net income forecast?

Harrow Health's net income forecast for the fiscal year ending in December 2025 stands at $21.49M, representing a -222.94% decrease from the reported $-17.481M in 2024. Projections indicate $91.07M in 2026, and $174.88M in 2027.